CONNECT WITH US
Funding Tracker

Funding Tracker

Nutrition startup Ace Blend raises $9.91 Mn led by 3one4 Capital

Entrackr logo

Published on

Add as a preferred source on Google
Nutrition startup Ace Blend raises $9.91 Mn led by 3one4 Capital

Ace Blend, a nutrition startup, has raised $9.91 million in a Series A2 funding round led by 3one4 Capital, with existing investor Fireside Ventures doubling down on its investment.

Fireside Ventures had previously led the company’s $3.3 million pre-Series A round.

The fresh capital will support research-led product development and the launch of new nutrition formats.

The company claims that it grew 300% in FY26, while more than 46% of its customers returned to make repeat purchases. 

Founded by Shivam Hingorani, Ace Blend began selling its products in 2018. Saif Mehkri joined as co-founder in 2022, bringing nearly three decades of experience in the nutrition industry. The company operates an integrated supply chain covering ingredient sourcing, formulation and manufacturing.

Ace Blend develops nutritional products based on clinical evidence, focusing on nutrient forms, dosages and delivery methods. Its portfolio covers heart health, immunity, sleep, recovery and brain health. 

The company also works with global ingredient suppliers DSM and TCI, which have granted it exclusive rights in India to certain technologies.

Its products are developed by an in-house clinical team and recommended by a network of more than 400 doctors. Clinical validation and automated testing are conducted independently by accredited laboratories in Europe.

Ace Blend also holds issued patents for new nutrition formats designed for everyday use, with the first products expected to reach the market in the fourth quarter of FY27. 



Source link
Related Topics:Funding Tracker

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.